Malignant Bone Neoplasm — Trials

Malignant Bone Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

152 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 38
Recruiting: 17
Ph III recruiting: 1
Growth YoY: —
Industry share: 5%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 31.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (18)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07820033	Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled Trial(PEARL RCT)	not yet recruiting	Phase 2	46	University Health Network, TorontoOTHER	1	Sep 15, 2026	clinicaltrials
NCT07560410	Treatment of Truncated ALK-positive Bone Cancer Using Crizotinib (Xalkori) or Alectinib (Alecensa)	not yet recruiting	Phase 1 / Phase 2	10	China Medical University HospitalOTHER	1